03/18/2024 3:29 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:31 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 4:30 PM | Arch Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/15/2024 3:30 PM | Arch Therapeutics (Filer)
| Form NT 10-Q | |
01/22/2024 11:39 AM | Arch Therapeutics (Subject) Parker Michael Andrew (Filed by)
| Form SC 13G/A | |
01/12/2024 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
12/29/2023 3:30 PM | Arch Therapeutics (Filer)
| Form NT 10-K | |
12/15/2023 3:31 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 3:34 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 3:33 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2023 3:47 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 5:50 AM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 7:33 PM | Arch Therapeutics (Filer)
| Form S-1/A | |
10/05/2023 4:27 PM | Arch Therapeutics (Filer)
| Form S-1/A | |
09/27/2023 4:12 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 4:47 PM | Arch Therapeutics (Issuer) Hicks Laurence (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 4:47 PM | Arch Therapeutics (Issuer) Norchi Terrence W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 4:47 PM | ABRAMS MICHAEL S (Reporting) Arch Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2023 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 3:30 PM | Arch Therapeutics (Filer)
| Form DEF 14C | |
08/23/2023 7:30 AM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/22/2023 3:52 PM | Arch Therapeutics (Filer)
| Form PRE 14C | |
08/11/2023 4:20 PM | Arch Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023 10:16 AM | Arch Therapeutics (Subject) Stahl Andrew (Filed by)
| Form SC 13G | |
08/04/2023 3:31 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 3:32 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/14/2023 8:00 AM | Arch Therapeutics (Subject) BIGGER CAPITAL FUND L P (Filed by)
| Form SC 13G | |
07/13/2023 4:26 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 4:00 PM | Arch Therapeutics (Subject) Oasis Capital, LLC (Filed by)
| Form SC 13G | |
07/07/2023 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 3:30 PM | Arch Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |